Health Affairs' Editor-in-Chief Alan Weil interviews Richard Hughes IV of Epstein Becker Green and George Washington University about his recent paper that reviewed school-entry vaccine policies on a ...
US taxpayers provide enormous contributions to global biomedical research and drug development, investing $54 billion in 2023. Yet, US patients also face the highest brand-name drug prices in the ...
In a WTOP-FM interview, Health Affairs Editor-In-Chief Alan Weil discusses what the US can expect for health policy under the incoming Trump administration. Weil also discussed an article from the ...